COLTENE HOLDING AG |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 50.7 CHF | -0.98% |
|
-7.55% | -28.21% |
| Mar. 08 | Switzerland's Coltene Appoints Successor to Outgoing Chair | MT |
| Mar. 08 | Switzerland's Coltene Logs Lower FY23 Net Profit, Sales | MT |
| Sales 2024 * | 249M 274M | Sales 2025 * | 258M 284M | Capitalization | 318M 350M |
|---|---|---|---|---|---|
| Net income 2024 * | 20M 22M | Net income 2025 * | 22M 24.2M | EV / Sales 2024 * | 1.36 x |
| Net Debt 2024 * | 20.92M 23.01M | Net Debt 2025 * | 17.81M 19.59M | EV / Sales 2025 * | 1.3 x |
| P/E ratio 2024 * |
13.8
x | P/E ratio 2025 * |
12.9
x | Employees | 1,216 |
| Yield 2024 * |
4.84% | Yield 2025 * |
5.26% | Free-Float | 43.05% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.98% | ||
| 1 week | -7.55% | ||
| Current month | -10.76% | ||
| 1 month | -10.14% | ||
| 3 months | -9.82% | ||
| 6 months | -19.81% | ||
| Current year | -28.21% |
1 week
51.40
56.80
1 month
51.4059.00
Current year
51.4070.90
1 year
51.4079.30
3 years
51.40135.00
5 years
51.40135.00
10 years
50.00135.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dominik Arnold
CEO | Chief Executive Officer | 52 | Dec. 31 |
| Director of Finance/CFO | 45 | 21-12-31 | |
Gregor Picard
COO | Chief Operating Officer | 54 | 23-03-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jürgen Rauch
BRD | Director/Board Member | 57 | 15-12-31 |
Nick Huber
CHM | Chairman | 60 | 07-12-31 |
Roland Weiger
BRD | Director/Board Member | 63 | 13-04-14 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 51.4 | +0.39% | 1 741 |
| 24-04-18 | 53.2 | +0.38% | 4,993 |
| 24-04-17 | 53 | -2.93% | 5,725 |
| 24-04-16 | 54.6 | -2.85% | 7,282 |
| 24-04-15 | 56.2 | +1.08% | 1,911 |
Delayed Quote Swiss Exchange, April 19, 2024 at 06:29 am EDT
More quotes
Coltene Holding AG is a Switzerland-based Company active in the healthcare sector. It develops, manufactures and sells dental consumables and small equipment focusing on mechanical instruments and filling materials. It has production facilities in Switzerland, the United States, Germany and Hungary. The Company's product range comprises six product groups: Adhesives / Restoratives; Endodontics; Prosthetics; Rotary Instruments; Treatment Auxiliaries; and Hygiene. Coltene Holding AG has a number of wholly owned subsidiaries active in production and sales of dental specialties based in Switzerland, Germany, Hungary, Canada, the United Kingdom, France, China, India, the United States and Brazil.
Calendar
2024-08-07
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
53.2
CHF
Average target price
62
CHF
Spread / Average Target
+16.54%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -28.21% | 349M | |
| -4.36% | 183B | |
| -3.87% | 105B | |
| -4.38% | 67.36B | |
| +8.23% | 51.77B | |
| +15.54% | 47.29B | |
| -1.73% | 40.2B | |
| +7.16% | 27.62B | |
| -16.62% | 21.75B | |
| -1.68% | 25.51B |
- Stock Market
- Equities
- CLTN Stock
